Myomo Stock Plunges 37.5% on Revenue Forecast Cut

On August 12, 2025, Myomo's stock experienced a significant drop of 37.5% in pre-market trading, marking a substantial decline in its share price.

Myomo, a manufacturer of wearable medical robotics, recently slashed its 2025 revenue forecast, which has raised concerns among investors. The company's decision to lower its revenue expectations has led to a sharp decline in investor confidence, resulting in a significant sell-off of its shares.

This move by Myomo comes as a surprise to many, as the company had previously been seen as a promising player in the medical device sector. The reduction in revenue forecast suggests that the company may be facing challenges in its operations or market conditions, which has led to a negative reaction from investors.